NCT03519074View on ClinicalTrials.gov

Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 22, 2016

Primary Completion Date

September 1, 2024

Study Completion Date

December 20, 2025

Conditions
CancerLiver Dysfunction
Interventions
DRUG

TS-1 combined with cisplatin

Cisplatin 60mg/m2, day 1, every 21 days Oral TS-1 30mg/m2 bd, days 1-14, every 21 days (absolute dose of oral TS-1 will be 40-60mg bd days 1-14, every 21 days, depending on body surface area)

Trial Locations (2)

119228

National University Hospital, Singapore

609606

Ng Teng Fong General Hospital, Singapore

All Listed Sponsors
lead

National University Hospital, Singapore

OTHER